EATG, News WHO: The use of delamanid in the treatment of MDR-TB in children and adolescents: Interim policy guidance November 18, 2016 1632
Facebook Twitter Google+ Post Views: 1,632 TBTreatmentWHO Share the News Facebook Twitter VKontakte Google+ European Antibiotic Awareness Day 2016 Genetically engineered T cells render HIV’s harpoon powerless Related News 2049 Behavioral intervention reduces HIV transmission risk in young transgender women 2538 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis 2518 Vladimir Zhovtyak: European AIDS conference is a step forward to control the HIV/AIDS in Europe 2361 Patient Communities Agree on Shared Vision of HIV Treatment Regimen 2893 Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
2538 Global progress towards hepatitis C elimination still blocked by cost of treatment, lack of diagnosis
ПОИСК ПО САЙТУ 
поиск по ресурсному центру 
